Venquis Therapeutics | Venquis Therapeutics

The Venquis Platform

Transformational Chemical-Biology Platform

Transformational Chemical-Biology Platform

Transformational Chemical-Biology Platform

Transformational Chemical-Biology Platform

We use powerful chemical screens that enable new classes of small molecule drugs to target mutant proteins with specificity

Oncology and Degenerative Diseases

Transformational Chemical-Biology Platform

Transformational Chemical-Biology Platform

Oncology and Degenerative Disease

We harness the power of protein degradation for oncology and degenerative diseases

Experienced Founders

Transformational Chemical-Biology Platform

Experienced Founders

Experienced Startup Team

We are an experienced team both in drug discovery and in platform development

Venquis Key Advantages

Small Molecule Degraders are a new class of Targeted Degraders

They target a protein directly for destruction

Can target the driver mutations of disease

Activity drives the biology, which is targeted through chemistry

Powerful chemical biology technology discovers and refines the chemistry

Chemical starting points use low hanging fruit
Even moderate binders can induce near complete degradation

Programs target areas of high unmet medical need

Potential for quick wins

Our Goal: True small molecules that uniquely and specifically drive target degradation only on mutated proteins